Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

Understanding Of Antidepressant Drugs Enhanced By New Mouse Model Of Depression/Anxiety
A recent study finds that the antidepressant effects of drugs like Prozac involve both neurogenesis-dependent and -independent mechanisms, a finding that may lead to development of better treatments for depression and anxiety. The research, published by Cell Press in the May 28th issue of the journal Neuron, utilizes a new experimental mouse model of depression/anxiety that is the first to permit simultaneous examination of multiple effects of antidepressant treatment in the same animal.
generic viagra online
Swine Flu Media Bulletin Spread And Extent Of The Outbreak (Information As At 5pm On 27 May), Wales
- 0 confirmed cases in Wales.
News of the day
Genetic Immunity, InPlay Completes Patient Enrollment In Phase II Trial Of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
Power of the Dream Ventures, Inc. (OTCBB: PWRV), Hungary"s premier technology acquisition and development company, is pleased to present this Genetic Immunity release, based on a previously announced agreement whereby Power of the Dream Ventures will issue communications for Genetic Immunity on a going forward basis.
Health Insurance

Inovio Biomedical To Present At International DNA Vaccine Conference

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it will make multiple presentations at the Annual Conference of DNA Vaccines in Asia 2009 being hosted by the International Society of DNA Vaccines July 9 - 10 at the Beijing International Convention Center. The conference, with the theme, "Advancing DNA Vaccine Technology," is co-chaired by David B. Weiner, Ph.D., professor of pathology, University of Pennsylvania School of Medicine, and chairman of Inovio"s scientific advisory board. Inovio scientists and associates will be making the following presentations: Engineering Highly Immune Potent DNA Vaccines by Engineering Molecular Biology, Immunology and Physical Delivery In Vivo Presidential Address and Keynote Lecture David B. Weiner, Ph.D. Thursday July 9 08:30 - 09:05 Location: 305BC Immune Therapy by Electroporation Plenary Session 2 Iacob Mathiesen, Ph.D., Managing Director, Inovio AS Thursday July 9 11:00 - 12:10 Location: 305BC Pandemic and Seasonal Influenza DNA Vaccines Delivered via Electroporation Plenary Session 3 Niranjan Y. Sardesai, Ph.D., Sr. VP, Research & Development, Inovio Biomedical Thursday July 9 13:10 - 14:55 Location: 305BC Special Considerations for Multi-Component DNA Vaccine Production Plenary Session 7 Henry Hebel, Chief Operating Officer, VGXI Inc. Friday July 10 11:00 - 12:10 Location: 305BC Inovio Biomedical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009